Table 1. Patient characteristics (N=88).
| Variable | Value |
|---|---|
| Age at primary treatment (years) | 56 [31–70] |
| ≤60 y, n (%) | 64 (72.7) |
| >60 y, n (%) | 24 (27.3) |
| Sex, n (%) | |
| Male | 72 (81.8) |
| Female | 16 (18.2) |
| BMI, n (%) | |
| <18.5 kg/m2 | 13 (14.8) |
| 18.5–23.9 kg/m2 | 53 (60.2) |
| ≥24 kg/m2 | 22 (25.0) |
| Tumor location, n (%) | |
| Proximal third | 10 (11.4) |
| Middle third | 65 (73.9) |
| Distal third | 13 (14.8) |
| Clinical T stage, n (%) | |
| cT2 | 15 (17.0) |
| cT3 | 52 (59.1) |
| cT4 | 21 (23.9) |
| Clinical N stage, n (%) | |
| N0 | 8 (9.1) |
| N1 | 80 (90.9) |
| Clinical stage group, n (%) | |
| IIB | 15 (17.0) |
| III | 73 (83.0) |
BMI, body mass index.